When is LMAT's latest earnings report released?
The most recent financial report for Lemaitre vascular, inc. (LMAT) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating LMAT's short-term business performance and financial health. For the latest updates on LMAT's earnings releases, visit this page regularly.
Where does LMAT fall in the P/E River chart?
According to historical valuation range analysis, Lemaitre vascular, inc. (LMAT)'s current price-to-earnings (P/E) ratio is 44.86, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
What is the operating profit of LMAT?
According to the latest financial report, Lemaitre vascular, inc. (LMAT) reported an Operating Profit of 18.83M with an Operating Margin of 29.22% this period, representing a growth of 46.51% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is LMAT's revenue growth?
In the latest financial report, Lemaitre vascular, inc. (LMAT) announced revenue of 64.45M, with a Year-Over-Year growth rate of 15.68%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much debt does LMAT have?
As of the end of the reporting period, Lemaitre vascular, inc. (LMAT) had total debt of 185.59M, with a debt ratio of 0.3. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
How much cash does LMAT have?
At the end of the period, Lemaitre vascular, inc. (LMAT) held Total Cash and Cash Equivalents of 28.24M, accounting for 0.05 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does LMAT go with three margins increasing?
In the latest report, Lemaitre vascular, inc. (LMAT) achieved the “three margins increasing” benchmark, with a gross margin of 71.7%%, operating margin of 29.22%%, and net margin of 24.2%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess LMAT's profit trajectory and future growth potential.
Is LMAT's EPS continuing to grow?
According to the past four quarterly reports, Lemaitre vascular, inc. (LMAT)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.69. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of LMAT?
Lemaitre vascular, inc. (LMAT)'s Free Cash Flow (FCF) for the period is 21.38M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 62.73% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of LMAT?
The latest valuation data shows Lemaitre vascular, inc. (LMAT) has a Price-To-Earnings (PE) ratio of 44.86 and a Price/Earnings-To-Growth (PEG) ratio of -2.84. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.
